폐섬유증과 폐렴의 차이를 비교하면, 폐섬유증을 이해하는데 도움이 되는 것 같습니다. 폐에서 발생하지만 완전히 다른 두 질병의 차이를 통해 연구하시는데 조금이나마 도움이 되시길 바랍니다.
특발성 폐 섬유증 | 방사성 폐렴 | |
Triggering factors | Repetitive injury to the aging genetically susceptible alveolar epithelium | Direct and indirect injury of ionizing radiation to the AECs and vascular endothelial cells |
Major role | fibroproliferative response (fibroproliferative repair phase becomes dominant under the influence of high levels of TGF-beta) | Inflammatory response |
Early cellular effects of the triggering factors | Dysfunctional alveolar epithelial cells lead to a dysregulated repair course and type II cells cannot regenerate damaged cells. Apoptosis of alveolar epithelial cells, remarkable loss of type I cells and proliferation/ hyperplasia of type II cells are characteristic findings of IPF | radiation pneumonitis is mediated by DNA damage, oxidative stress (ROS), and dysregulation of various fibroinflammatory molecules. Radiation pneumonitis is associated with type 1 T-helper (Th1) immune response and alveolar M1 macrophages become activated with the increase of Th1 derived interferon gamma (IFN-γ) |
Effects on vascular permeability |
Increased vascular permeability Protein leakage into alveolar and interstitial spaces Formation of a provisional matrix, “wound clot" | Increased vascular permeability Interstitial and intraalveolar accumulation of inflammatory cells and proteins Interstitial and alveolar edema |
Repair feature | Relatively strong fibroproliferative response, Relatively weak inflammatory response Aberrant repair mechanisms | Relatively strong inflammatory response, Relatively weak fibroproliferative response. Dysregulation of fibroinflammatory molecules and non-healing tissue response |
Pivotal cellular mediator |
Myofibroblasts | Alveolar macrophages |
Response to the cell injury |
Migration, proliferation and aberrant activation of epithelial cells GF/cytokine/chemokine release, mainly by AECs Formation of small fibroblast clusters, “fibroblastic foci” The EMT process, mainly through TGF-β1 | GF/cytokine/chemokine release, mainly by activated alveolar macrophages Th1 immune response: alveolar M1 macrophage activation by Th-1 derived IFN-c Inflammation, increased inflammatory cell and protein accumulation in the interstitium Cell death |
Reinforced fibrogenic milieu |
Coagulation cascade activation Prevention of degradation of the provisional matrix by activated Factor X | Coagulation cascade activation |
Abnormal lung remodeling |
Excessive ECM secretion by myofibroblasts Basement membrane destruction through MMP2/MMP9 activation The additional effects of recruited fibrocytes through the CXCR4/CXCL12 axis Collagen deposition, fibrosis and scarring | Inflammatory cell infiltration Alveolar and interstitial edema Impaired lung functions and collapse |
'심각한_질병이야기 > Respiratory disorder' 카테고리의 다른 글
대웅제약 DWN1208 [국내 IPF 치료 약물 개발 1] (0) | 2022.09.20 |
---|---|
현재까지 알려진 COPD biomarker 모음 (0) | 2022.09.15 |
Pamrevlumab(FG-3019)_특발성 폐 섬유증(IPF) 치료제의 연구내용 (0) | 2022.07.02 |
COPD Unmet medical need (0) | 2022.06.21 |
폐암관련 가이드라인 모음 (0) | 2022.03.01 |